{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2021-11-16T00:00:00", "title": "AO 21-16", "url": "https://oig.hhs.gov/compliance/advisory-opinions/21-16/", "attachments": [{"title": "Advisory Opinion 21-16", "url": "https://oig.hhs.gov/documents/advisory-opinions/1008/AO-21-16.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-21-16", "subagency": "Office of the Inspector General", "summary": "Regarding a pharmaceutical manufacturer\u2019s arrangement to provide up to a specified number of trial units of a long-acting antipsychotic drug to certain hospitals for inpatient use."}